title: Acute intestinal injury induced by acetic acid and casein: prevention by intraluminal misoprostol.
abstract: Acute injury was established in anesthetized rabbits by intraluminal administration of acetic acid with and without bovine casein, into loops of distal small intestine. Damage was quantified after 45 minutes by the blood-to-lumen movement of 51Cr-labeled ethylenediaminetetraacetic acid (EDTA) and fluorescein isothiocyanate-tagged bovine serum albumin as well as luminal fluid histamine levels. The amount of titratable acetic acid used to lower the pH of the treatment solutions to pH 4.0 was increased by the addition of calcium gluconate. Luminal acetic acid caused a 19-fold increase in 51Cr-EDTA accumulation over saline controls; casein did not modify this effect. In saline controls, loop fluid histamine levels bordered on the limits of detection (1 ng/g) but were elevated 19-fold by acetic acid exposure and markedly increased (118-fold) by the combination of acid and casein. Intraluminal misoprostol (3 or 30 micrograms/mL), administered 30 minutes before acetic acid, significantly attenuated the increase in epithelial permeability (luminal 51Cr-EDTA, fluorescein isothiocyanate-bovine serum albumin accumulation) and histamine release (P less than 0.05). Diphenhydramine, alone or in combination with cimetidine, and indomethacin (5 mg/kg IV) were not protective. It is concluded that exposure of the epithelium to acetic acid promotes the transepithelial movement of casein leading to enhanced mast cell activation and mucosal injury. Damage to the epithelial barrier can be prevented by misoprostol.
authors.affiliation: Department of Pediatrics, Louisiana State University School of Medicine, New Orleans.
authors.forename: M J
authors.initials: MJ
authors.lastname: Miller
authors.forename: X J
authors.initials: XJ
authors.lastname: Zhang
authors.forename: X A
authors.initials: XA
authors.lastname: Gu
authors.forename: D A
authors.initials: DA
authors.lastname: Clark
mesh_terms: D000085:Acetates / Q000633:toxicity*; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D002125:Calcium Gluconate / Q000633:toxicity; D002364:Caseins / Q000633:toxicity*; D002463:Cell Membrane Permeability / Q000187:drug effects; D002860:Chromium Radioisotopes; D004357:Drug Synergism; D004492:Edetic Acid; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins; D005456:Fluorescent Dyes; D006632:Histamine / Q000378:metabolism; D006633:Histamine Antagonists / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007213:Indomethacin / Q000494:pharmacology; D007421:Intestine, Small / Q000187:drug effects* / Q000473:pathology* / Q000503:physiopathology; D008297:Male; D016595:Misoprostol; D011817:Rabbits; D012710:Serum Albumin, Bovine; D013861:Thiocyanates
chemical_list: D000085:Acetates; D002364:Caseins; D002860:Chromium Radioisotopes; D005452:Fluoresceins; D005456:Fluorescent Dyes; D006633:Histamine Antagonists; D013861:Thiocyanates; D016595:Misoprostol; D012710:Serum Albumin, Bovine; D006632:Histamine; D004492:Edetic Acid; D000527:Alprostadil; D016650:Fluorescein-5-isothiocyanate; D002125:Calcium Gluconate; D007213:Indomethacin